BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17413657)

  • 1. Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation.
    Johansson AS; Bergquist J; Volbracht C; Päiviö A; Leist M; Lannfelt L; Westlind-Danielsson A
    Neuroreport; 2007 Apr; 18(6):559-63. PubMed ID: 17413657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.
    Misiti F; Clementi ME; Giardina B
    Neurochem Int; 2010 Mar; 56(4):597-602. PubMed ID: 20060866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide.
    Butterfield DA; Bush AI
    Neurobiol Aging; 2004; 25(5):563-8. PubMed ID: 15172731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell.
    Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F
    Int J Biochem Cell Biol; 2004 Oct; 36(10):2066-76. PubMed ID: 15203119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
    Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta(31-35) peptide induce apoptosis in PC 12 cells: contrast with Abeta(25-35) peptide and examination of underlying mechanisms.
    Misiti F; Sampaolese B; Pezzotti M; Marini S; Coletta M; Ceccarelli L; Giardina B; Clementi ME
    Neurochem Int; 2005 Jun; 46(7):575-83. PubMed ID: 15843052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
    Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
    Päiviö A; Jarvet J; Gräslund A; Lannfelt L; Westlind-Danielsson A
    J Mol Biol; 2004 May; 339(1):145-59. PubMed ID: 15123427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of methionine 35 inhibits apoptotic effects of Abeta(31-35) and Abeta(25-35) fragments of amyloid-beta protein in PC12 cells.
    Clementi ME; Misiti F
    Med Sci Monit; 2005 Nov; 11(11):BR381-5. PubMed ID: 16258386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
    Boyd-Kimball D; Mohmmad Abdul H; Reed T; Sultana R; Butterfield DA
    Chem Res Toxicol; 2004 Dec; 17(12):1743-9. PubMed ID: 15606152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.
    Stege GJ; Renkawek K; Overkamp PS; Verschuure P; van Rijk AF; Reijnen-Aalbers A; Boelens WC; Bosman GJ; de Jong WW
    Biochem Biophys Res Commun; 1999 Aug; 262(1):152-6. PubMed ID: 10448084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid beta-protein fragment (31-35) on isolated brain mitochondria.
    Misiti F; Martorana GE; Nocca G; Di Stasio E; Giardina B; Clementi ME
    Neuroscience; 2004; 126(2):297-303. PubMed ID: 15207347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35.
    Clementi ME; Pezzotti M; Orsini F; Sampaolese B; Mezzogori D; Grassi C; Giardina B; Misiti F
    Biochem Biophys Res Commun; 2006 Mar; 342(1):206-13. PubMed ID: 16472763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
    Rauk A
    Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's A beta(1-42): relevance to N-terminal methionine chemistry in small model peptides.
    Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
    Peptides; 2005 Apr; 26(4):665-73. PubMed ID: 15752582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
    Narayanan S; Kamps B; Boelens WC; Reif B
    FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
    Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
    J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.